FDA.reportPublic FDA data

adalimumab-adaz 10 MG in 0.1 ML Prefilled Syringe

RxCUI
2641644
RxNorm name
adalimumab-adaz 10 MG in 0.1 ML Prefilled Syringe
Display name
adalimumab-adaz 10 MG in 0.1 ML Prefilled Syringe
Full name
adalimumab-adaz 10 MG in 0.1 ML Prefilled Syringe
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:53

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761071Hyrimozadalimumab-adaz351(k) InterchangeableRx2026-06-01

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
3468792f-63ef-4916-8ed1-8214f327d9ddadalimumab-adaz 10 MG per 0.1 ML Prefilled SyringeSY15These highlights do not include all the information needed to use ADALIMUMAB-ADAZ safely and effectively. See full prescribing information for ADALIMUMAB-ADAZ. ADALIMUMAB-ADAZ injection, for subcutaneous use Initial U.S. Approval: 2018 This product is HYRIMOZ (adalimumab-adaz). HYRIMOZ (adalimumab-adaz) is biosimilar* to HUMIRA ® (adalimumab).20251021
3468792f-63ef-4916-8ed1-8214f327d9dd0.1 ML adalimumab-adaz 100 MG/ML Prefilled SyringeSCD15These highlights do not include all the information needed to use ADALIMUMAB-ADAZ safely and effectively. See full prescribing information for ADALIMUMAB-ADAZ. ADALIMUMAB-ADAZ injection, for subcutaneous use Initial U.S. Approval: 2018 This product is HYRIMOZ (adalimumab-adaz). HYRIMOZ (adalimumab-adaz) is biosimilar* to HUMIRA ® (adalimumab).20251021
3468792f-63ef-4916-8ed1-8214f327d9ddadalimumab-adaz 10 MG in 0.1 ML Prefilled SyringePSN15These highlights do not include all the information needed to use ADALIMUMAB-ADAZ safely and effectively. See full prescribing information for ADALIMUMAB-ADAZ. ADALIMUMAB-ADAZ injection, for subcutaneous use Initial U.S. Approval: 2018 This product is HYRIMOZ (adalimumab-adaz). HYRIMOZ (adalimumab-adaz) is biosimilar* to HUMIRA ® (adalimumab).20251021
1ac7d061-3380-468c-b077-c05f8dfbc829adalimumab-adaz 10 MG in 0.1 ML Prefilled SyringePSN13These highlights do not include all the information needed to use HYRIMOZ ® safely and effectively. See full prescribing information for HYRIMOZ. HYRIMOZ (adalimumab-adaz) injection, for subcutaneous use Initial U.S. Approval: 2018 HYRIMOZ (adalimumab-adaz) is biosimilar* to HUMIRA ® (adalimumab)20251017
1ac7d061-3380-468c-b077-c05f8dfbc8290.1 ML adalimumab-adaz 100 MG/ML Prefilled SyringeSCD13These highlights do not include all the information needed to use HYRIMOZ ® safely and effectively. See full prescribing information for HYRIMOZ. HYRIMOZ (adalimumab-adaz) injection, for subcutaneous use Initial U.S. Approval: 2018 HYRIMOZ (adalimumab-adaz) is biosimilar* to HUMIRA ® (adalimumab)20251017
1ac7d061-3380-468c-b077-c05f8dfbc829adalimumab-adaz 10 MG per 0.1 ML Prefilled SyringeSY13These highlights do not include all the information needed to use HYRIMOZ ® safely and effectively. See full prescribing information for HYRIMOZ. HYRIMOZ (adalimumab-adaz) injection, for subcutaneous use Initial U.S. Approval: 2018 HYRIMOZ (adalimumab-adaz) is biosimilar* to HUMIRA ® (adalimumab)20251017